Abstract
Biomarkers are the essential tools for the implementation of personalized medicine. In recent years, the ready availability of powerful tools to scan both the genome and the proteome of an organism have revolutionized and greatly accelerated biomarker discovery. In this chapter, a brief review of how novel biomarkers are discovered and validated and what the general characteristics of an ideal biomarker are, are presented. These general principles are then applied specifically to emerging biomarkers of acute kidney injury and chronic kidney disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
